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The contribution of neutrophils to asthma pathogenesis has been mainly studied in the context 
of non-allergic neutrophilic asthma. However, neutrophils can also be rapidly recruited and are 
largely present in the airways of allergic eosinophilic asthmatic patients. Under these 
circumstances, they possess specific phenotypic features distinguishing them from resting blood 
neutrophils and are endowed with particular functions. The exact contribution of neutrophils to 
allergic asthma pathogenesis is still unclear, but growing experimental evidence supports the 
ability of neutrophils or neutrophil-derived products to influence the underlying allergic type 2 
immune response and cardinal features of allergic asthma, thus shedding new light on 
neutrophil biology and functions in an allergic context. 
Introduction 
Neutrophils represent the most abundant immune cell type in the blood and are generated in the 
bone marrow under the control of key transcriptor factors such as C/ EBPα, PU.1, Gfi-1 and 
C/EBPε [1]. They have long been known as short-lived (half-life: 6-12 hours [2]) innate immune 
cells specialized in pathogen killing through their high phagocytic potential and the secretion of 
cytotoxic granules once recruited in the tissues [1]. Today, a more complex picture of the 
neutrophil is emerging, with immunoregulatory properties and implications in various non-
infectious disorders [3]. Of note, unlike previously appreciated, neutrophils are now thought to 
encompass distinct phenotypic and functional subsets in humans [4,5] and mice [6,7], some of 
them exhibiting an extended half-life in certain inflammatory conditions [3]. Furthermore, in 
2004, Brinkmann and colleagues have discovered the ability of neutrophils to form neutrophil 
extracellular traps (NETs), whose roles in health and disease are currently under close scrutiny 
(Box 1), and which has arguably contributed to the renewed interest in neutrophils [8]. 
Asthma constitutes a heterogeneous group of respiratory inflammatory disorders characterized 
by a similar clinical pattern of cough, wheeze and reversible airway obstruction [9]. Asthma 
phenotypes can be categorized according to clinical symptoms, specific triggers, inflammatory or 
immune status, or treatment response [10,11]. If one refers to an inflammatory phenotype 
classification [12,13], allergic asthma belongs to the 'eosinophilic' phenotype (Table 1). Notably, 
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while patients with more than 3% sputum eosinophils are considered 'eosinophilic', up to 60% 
sputum neutrophils can also be present [10,12,13]. Immunologically, allergic asthma is 
characterized by the development of an aberrant immune response with a predominant 
adaptive type 2 T helper cell (Th2) profile directed against inhaled allergens [9]. Such Th2 
response, via the secretion of cytokines such as interleukin(IL)-4, IL-5, IL-13, orchestrates many 
cardinal features of allergic asthma, such as eosinophilic inflammation, mucus hypersecretion, 
airway hyper-responsiveness and increased serum levels of type E immunoglobulins (IgE) [14]. 
Neutrophil recruitment in allergic asthmatic lungs 
While neutrophils are not steadily present in the airways of allergic asthmatic patients, they are 
one of the first innate immune cells recruited into the lungs during specific asthma-related 
events such as allergenic challenges [15-17], virus-induced asthma exacerbations [18•• ,19,20] or 
nocturnal crises [21]. In mice, airway exposure to clinically relevant allergens that promote 
features of allergic asthma is also associated with the airway recruitment of neutrophils 
[18",22",23∙,24]. 
Like in other tissues, the recruitment of neutrophils into the respiratory tract comprises several 
steps that are initiated by the endothelial expression of adhesion molecules [25] and followed by 
extravasation and migration according to a chemokine gradient. In a mouse model of ragweed 
pollen extract challenge, Hosoki and colleagues demonstrated that lung neutrophil recruitment 
was substantially lower in mice lacking the LPS receptor Toll like receptor (TLR)-4 [22"]. 
Similarly, inhibition of CXCR2, the receptor for CXCL1, CXCL2 and CXCL5 in mice, inhibited 
allergen-induced innate recruitment of neutrophils [22"], and the production of CXCL1, CXCL2 
and CXCL5 was shown to be dependent on TLR-4 and its co-receptor MD2 in response to cat 
dander and other relevant pollens [22••,23•]. Epithelial cells might be the source of such 
chemokines, as they have been shown, in humans, to secrete CXCL8 (i.e. IL-8, the human 
analogue of CXCL1, CXCL2 and CXCL5) following allergenic challenges [23•,26]. In addition, 
alveolar macrophages may also deliver CXCL1 and CXCL2 in response to allergen-induced and 
antibody-mediated activation of FCγ III receptors [27]. In humans, sputum levels of CXCL8 have 
been shown to be increased during acute allergic asthma exacerbations [19] and following 
allergenic challenge [15], which was associated with increased sputum neutrophils and blood 
neutrophil chemotaxis [15].  
Oyoshi and colleagues demonstrated, in a model of skin allergy, that neutrophil-intrinsic 
leukotriene B4 (LTB4) synthesis and its receptor, BLT1, were involved in neutrophil 
recruitment [28]. Interestingly, LTB4 levels were increased in the BALF of asthmatic patients 
suffering from nocturnal asthma [29] and in exhaled breath condensate of asthmatic children 
[30] and adults [31]. In addition, the use of a LTB4 inhibitor in asthmatic patients triggered a 
substantial decrease in BALF neutrophils [32]. 
The Th2-associated cytokine IL-4 may control neutrophil recruitment during allergic asthma. 
Indeed, a recent study has demonstrated that IL-4 could dampen neutrophil expansion and 
migration through neutrophil-intrinsic IL-4 receptor signaling in mice [33••]. Ex vivo treatment 
of bone marrow neutrophils with IL-4 inhibited neutrophil migration in response to CXCL1 and 
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CXCL2 by IL-4 receptor-dependent mechanisms [33••]. In a model of airpouch, CXCR2-dependent 
neutrophil recruitment was also inhibited when IL-4 biological half-life was prolonged [30]. The 
potential contribution of the IL-4/IL-4 receptor axis to the regulation of neutrophil numbers in 
the airways of allergic asthmatic patients or experimental animals will however require further 
investigations. Mast cells, whose allergen-dependent and IgE-dependent degranulation is 
thought to contribute to the acute allergic reaction [34], may also negatively regulate neutrophil 
influx in allergic asthmatics airways. Indeed, levels of mast cell-specific tryptase were found 
elevated in BALF of eosinophilic asthmatic patients [35], and such tryptase has been shown to be 
a strong chemorepellent for neutrophils in vitro [36]. 
Box 1 Neutrophil extracellular traps. 
Neutrophil extracellular traps (NETs) are web-like structures composed of nuclear or 
mitochondrial chromatin associated to modified (e.g. citrullinated) histone proteins and 
decorated with 20-50 different proteins, such as neutrophil elastase, myeloperoxidase (MPO), 
LL37, cathepsin G, proteinase 3 or high mobility group protein B1. NETs can be released in the 
extracellular space in response to various microbial (e.g. bacteria, viruses, parasites, 
lipopolysacchar-ide [LPS]) and non-microbial (e.g. phorbol 12-myristate 13-acetate (PMA), 
crystals) stimuli. The molecular mechanisms of NET formation are not yet fully understood and 
may differ according to the stimuli (reviewed in [48]). Reactive oxygen species (ROS) formation, 
activation of the MEK/ERK pathway downstream of membrane receptors (PSGL1, RAGE, 
TLR2/4, Dectin 2, Fc-/R, Siglec 14), activation of autophagy (through the inhibition of mTOR 
pathway or the activation of the PI3K pathway) and induction of necroptosis have all been 
implicated in NET formation. If NETs were originally discovered for their role in bacterial killing 
[8], they have been more recently associated with non-infectious disorders like thrombosis, 
vasculitis, systemic lupus erythematosus, diabetes, cancer, asthma or chronic obstructive 
pulmonary disease (COPD) [60]. 
Table 1. Asthma inflammatory phenotypes 
Phenotype Inflammatory cells 
present in the airways 
Immunological and 
inflammatory biomarkers 











 Sputum neutrophils 
(<76%) 
Th2-associated cytokines 








Sputum IL-8 Severe Obesity Th17>»Th2 
 Neutrophils (>76%) Neutrophil elastase 
IL-1β 
TNF-α 
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and 142-3p [62] 
Paucigranul
ocytic 
Levels of sputum 
eosinophils <3% and 
neutrophils <76% 




High levels of sputum 
eosinophils (>3%) and 
neutrophils (>76%) 
? Severe Not defined Th2/Th17? 
Source: Adapted from [9,12,13]. 
Phenotypic and functional features of neutrophils in allergic 
asthma 
Several pieces of evidence support that neutrophils undergo profound changes in the blood and 
lungs of allergic asthmatic individuals. A recent clinical study compared the innate immune 
responses of two populations of children (i.e. Amish and Hutterite) sharing same ancestry, 
lifestyles but exposed to different levels of endotoxins [37••]. Briefly, Hutterite children, who are 
raised in an environment poor in endotoxins, are susceptible to allergic asthma, whereas Amish 
children live in endotoxin-rich homes and are protected against allergic asthma development 
[37••]. Notably, blood neutrophils from asthma-prone Hutterite children expressed higher levels 
of CXCR4 and CDllb, as well as lower levels of CD11c, as compared to the ones isolated from 
Amish children [37••]. Blood and nasal lavage neutrophils of atopic asthmatic patients have also 
been shown to express higher surface levels of CD49d than neutrophils of healthy subjects [5]. 
CD49d expression is further increased six hours after allergen challenge [5], suggesting a 
possible interaction between neutrophils and the specific allergens. Such interaction could be 
achieved by allergen-induced crosslinking of the high affinity IgE receptor (FcεRI), whose 
expression is higher in blood neutrophils from asthmatic patients [38] and increased during the 
pollen season [39]. Interestingly, the interaction between specific allergens and IgE/FcεRI on the 
neutrophil surface has been shown to enhance functional responses by increasing secretion of 
neutrophil products in asthmatic patients, like matrix metalloproteinase 9 (MMP-9) [40], 
neutrophil elastase (NE) [41], myeloperoxidase [42], IL-8 [43], eosinophil cationic protein [44] 
and reactive oxygen species (ROS) [45]. Moreover, as compared to neutrophils from healthy 
individuals, neutrophils from asthmatic patients exhibited boosted functional responses in vitro, 
such as an enhanced migratory capacity, a higher digestion phase in phagocytosis assays [46] 
and increased secretion of tumor necrosis factor (TNF)α, GM-CSF or interferon γ [47]. 
Recently, Toussaint and colleagues have shown, in a human experimental model of rhinovirus-
induced allergic asthma exacerbations, that rhinoviruses promoted the release of host double-
stranded DNA (dsDNA) and NE, two major NET components [48], supporting that NET-prone 
neutrophils were specifically recruited during asthma exacerbations. 
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Contribution of neutrophils to allergic asthma pathogenesis 
Given their large presence, their specific phenotype and their ability to secrete a wide range of 
products during allergic asthma, neutrophils are appealing candidates that may contribute to 
disease pathogenesis (Figure 1). 
Using a model of airway allergy, Hosoki and colleagues showed that impaired neutrophil 
recruitment in TLR-4-deficient mice or in wild-type mice treated with a CXCR2 inhibitor was 
associated with decreased eosinophilic inflammation, IgE, Th2 cytokines and mucus secretion 
[22••]. Transfer of wild-type neutrophils in the trachea of TLR-4-deficient mice was sufficient to 
restore the Th2 immune response and features of airway allergy in this model, supporting that 
neutrophils could facilitate allergic sensitization and inflammation [22••]. Surprisingly, in a 
clinical study including Japanese children with primary autoimmune neutropenia, the incidence 
of asthma in 'neutrophil-deficient' children was found to be substantially lower as compared to a 
group of control children, and returned to the control levels with the resolution of neutropenia 
[49], supporting that neutrophils may promote asthma onset in humans, too. 
Among the large range of neutrophil products, some of them have been identified to be present 
at higher levels in allergic asthmatic airways and to contribute in disease pathogenesis (Figure 
1). Upon ex vivo stimulation with a relevant allergen, MMP-9 release and respiratory burst (i. e. 
associated with the production of ROS) were found to be higher in neutrophils of allergic 
asthmatic patients as compared to control neutrophils [40,45]. To address the role of MMP-9 
and ROS in vivo, transgenic mice in which MMP-9 expression is lacking or ROS production is 
impaired have been subjected to a model of allergic asthma based on administration of 
ovalbumin (OVA) and the Th2 adjuvant alum [50-52]. Upon allergenic challenge, mice deficient 
in MMP-9 had an impaired recruitment of inflammatory cells, which was accompanied by a 
lower bronchial hyperreactivity, less IL-13 and fewer OVA-specific IgE [50,52]. Furthermore, 
Vermaelen and colleagues observed that the migration and maturation of dendritic cells, the 
main antigen-presenting cells responsible for Th2 sensitization, were compromised in the lungs 
of MMP-9-deficient mice, which could explain the altered development of the Th2 immune-
mediated airway allergy [52]. Similarly, ROS-impaired mice failed to develop eosinophilic 
inflammation, mucus secretion and IL-13 secretion [51], and the ability of splenocytes to secrete 
IL-13 upon stimulation was also impaired in those animals, supporting that the Th2 response 
was facilitated by ROS [51]. 
Neutrophils were found to be a major source of oncostatin M, an important player in mucosal 
barrier dysfunction [53], in allergic asthmatic patients [54]. The exact contribution of oncostatin 
M to allergic asthma is still unclear, but endotracheal treatment of mice with adenovirus 
expressing mouse oncostatin-M has been shown to be sufficient to promote features of allergic 
asthma [55]. 
During the challenge phase of a OVA/alum model, NE inhibition was associated with decreased 
mucus cell numbers, eosinophil recruitment, bronchial hyperreactivity and Th2 immune 
responses [56]. In addition, mice chronically exposed to NE developed mucus cell metaplasia 
and lung eosinophilic inflammation [57]. iln vitro, NE has been shown to induce expression of 
the mucin protein MUC5AC by human epithelial cells [58,59]. 
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In a recent study, NETs have been shown to be essential in mediating allergic asthma 
exacerbations elicited by rhinoviruses [18••] (Figure 1). Indeed, NETs were massively released 
in the lungs of rhinovirus-infected mice, and inhibition of NETs formation or degradation of 
NETs strongly diminished all the cardinal features of asthma exacerbations [18••]. Furthermore, 
in this model, injection of mouse dsDNA, a major NET component, was sufficient to recapitulate 
most of the hallmarks of exacerbation. Mechanistically, NETs were found to promote the 
recruitment of inflammatory dendritic cells to the lung, which mediate allergic response to 
house dust mites in mice. During rhinovirus-induced asthma exacerbations in humans, dsDNA 
levels strikingly correlated with NE BALF levels, with the levels of type 2 cytokines detected in 
nasal lavages and BALF, and with the clinical severity of the exacerbation [18••]. 
Figure 1 Putative contributions of neutrophils to allergic asthma 
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(a) Upon allergenic challenges, neutrophils are one of the first innate immune cells recruited to the airways. They are 
able to secrete matrix metalloproteinase 9 (MMP-9), reactive oxygen species (ROS), oncostatin-M, and neutrophil 
elastase (NE), among others via IgE-dependent mechanisms. MMP-9 induces the recruitment and maturation of lung 
dendritic cells, which mediate Th2 sensitization. ROS can interact with the activation of Th2 cells. Oncostatin-M has a 
global facilitating effect on asthma hallmarks. NE can stimulate mucus cell metaplasia, (b) During allergic asthma 
exacerbations provoked by respiratory viral infections, neutrophils can release NETs, which attract monocyte-derived 
dendritic cells (moDCs) into the lung and promote type 2-mediated exacerbations. 
Conclusions and perspectives 
Clinical evidence supports that neutrophils are recruited to the lungs of allergic asthmatic 
patients, especially during asthma symptomatic manifestations. In this context, the few studies 
that have looked at their potential implication in allergic asthma pathogenesis have underscored 
a potential pro-inflammatory, deleterious role, which facilitates type 2-mediated disease 
development. However, the contribution of neutrophils to allergic asthma and type 2 responses 
may have been understudied so far. Indeed, historically, they have been merely considered as 
first-line innate responders and effector cells in the context of type 17 host defence responses. 
Today, it is increasingly clear that neutrophils encompass distinct subsets and are endowed with 
many immunoregulatory properties. The use of high dimensional unbiased technologies, 
combined with novel transgenic tools that target specific neutrophil subsets should help 
uncovering their complex contributions to health, host defence and diseases in general, and to 
allergic disorders in particular 
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